Alloimmune Thrombocytopenia

• CLINICAL_TRIALS research · 2025-04-30
  Clinical Trial Update: An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia [EARLY_Phase 1]

  This clinical trial is an early-phase study evaluating CD19 CAR NK cells for treating refractory primary immune thrombocytopenia (alloimmune…

• CLINICAL_TRIALS trial_result · 2018-11-07
  Clinical Trial Update: A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia [Phase 2, Phase 3]

  Phase 2/3 clinical trial update on antenatal treatment for alloimmune thrombocytopenia, completed with results posted in 2018.